http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102648196-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F3-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F3-06 |
filingDate | 2010-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102648196-B |
titleOfInvention | Can be used as the preparation method of the compound of the inhibitor of SGLT2 |
abstract | The present invention relates to for the preparation of formula (I) compound: or the novel method of its pharmacologically acceptable salt or solvate, described method comprises: formula (VII) (VIII) (IX), makes wherein Mn 2 formula (VII) compound and wherein each Z for zinc species are the independent oxygen blocking group selected and wherein LGn 2 for formula (VIII) compound of leavings group reacts to generate corresponding formula (IX) compound in the mixture of ether solvents and hydrocarbon solvent; Formula (IX) compound is made to go protection to generate corresponding formula (I) compound. |
priorityDate | 2009-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 334.